3i Group, Oxford Nanopore, Improbable: The week’s best-read stories
FTSE 100’s 3i Group plummets as CEO sounds note of caution. Despite posting positive half-year results, Simon Borrows says PE firm “remains cautious in deployment of capital into new investment”. Oxford Nanopore sees share price surge after positive update. Oxford-based DNA and RNA sequencing specialist expects 2025 revenue growth to be at the top end … Continue reading 3i Group, Oxford Nanopore, Improbable: The week’s best-read stories
